Valuation: Proto Script Pharmaceutical Corp.

Market Cap 19.66L 17.25L 16.06L 14.77L 27.7L 19Cr 28.17L 1.91Cr 74.59L 9.31Cr 73.79L 72.2L 32Cr P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 20.13L 17.67L 16.45L 15.13L 28.37L 19Cr 28.86L 1.95Cr 76.41L 9.54Cr 75.59L 73.95L 33Cr EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
3 months+100.00%
6 months+100.00%
Current year+100.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-33.33%-60.00% 11.38T
+1.60%+8.51%-1.88%+74.09% 8.6TCr
-0.87%+4.64%+6.58%+79.34% 2.17TCr
-2.11%+5.15%-3.90%+9.41% 1.66TCr
+7.80%+8.19%+8.59%+17.89% 1.38TCr
-0.13%+0.17%+19.03%+33.65% 1.19TCr
-2.66%-3.54%+17.67%+83.42% 772.72Cr
-0.20%+2.02%+54.93%+114.38% 706.4Cr
+5.40%+20.79%-19.78%+0.44% 586.66Cr
+0.71%+4.71%+76.50%+87.42% 543.43Cr
Average +0.96%+3.83%+12.44%+44.01% 1.76TCr
Weighted average by Cap. +1.16%+4.41%+6.17%+61.48%

Financials

2015 2016
Net sales 9L 8L 7L 7L 12.42L 8.42Cr 12.63L 85.46L 33.45L 4.18Cr 33.09L 32.38L 14Cr 8L 7L 6L 6L 11.12L 7.54Cr 11.31L 76.49L 29.94L 3.74Cr 29.62L 28.98L 13Cr
Net income -1L -1L -1L -1L -2L -1.39Cr -2L -14.08L -6L -68.82L -5L -5L -2.38Cr -71.83L -63.04L -58.7L -53.99L -1.01Cr -69Cr -1.03Cr -6.96Cr -2.73Cr -34Cr -2.7Cr -2.64Cr -117.58Cr
Net Debt 27.07T 23.76T 22.12T 20.35T 38.14T 25.86L 38.8T 3L 1L 12.83L 1L 99.43T 44.31L 47.78T 41.93T 39.05T 35.92T 67.33T 45.65L 68.48T 5L 2L 22.64L 2L 2L 78.22L
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock